Brief: Adial Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements

Azora Therapeutics

23/08/2023 13:31

Aug 23 (Reuters) - 
  
    * ADIAL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ
LISTING
REQUIREMENTS

Source text for Eikon:  ID:nGNXDVCNM 
Further company coverage:  ADIL.O 

 ((reuters.briefs@thomsonreuters.com;))